Low Vitamin D and B Vitamins Linked to Mild Cognitive Impairment: What a 2026 Study Found

By Dr. John Bartemus, DC, CFMP, Functional Medicine Charlotte, PC. Published August 4, 2026.

Short answer: A 2026 study of 184 older adults found that those with mild cognitive impairment had significantly lower vitamin D, B1, B2, B6, and folate, along with higher blood sugar and blood pressure and elevated markers of neurodegeneration. Higher vitamin levels, especially vitamin D and B6, were associated with a lower probability of cognitive impairment. This is an association, not proof of cause, because the study was cross-sectional. Still, it reinforces a practical message: nutrient status and metabolic health belong in any conversation about protecting the aging brain.

Cognitive decline is one of the most feared parts of aging, and one of the most under-investigated from a nutritional angle. A study published in July 2026 in the journal Nutrients takes a careful look at the overlap between micronutrient status, brain biomarkers, and cognition in older adults. The findings are worth understanding, and so are the limits.

What the researchers did

Researchers at the ICMR-National Institute of Nutrition in Hyderabad, India, ran a community-based study of 184 adults aged 55 to 85 between January 2024 and March 2025. They measured a wide range of markers: blood sugar and blood pressure, blood levels of several vitamins, and neuronal biomarkers associated with brain health. Cognitive function was screened using the Montreal Cognitive Assessment (MoCA), a widely used and validated tool. Using the study’s threshold, 36.4 percent of participants met criteria for mild cognitive impairment (MCI), the intermediate stage between normal aging and dementia.

The brain biomarker picture

Before the vitamins, the study confirmed something important about the group with cognitive impairment: their brain biology looked measurably different. Compared with the non-MCI group, the MCI group had significantly higher levels of three markers associated with neurodegeneration, beta-amyloid, total tau, and neurofilament light chain (Nfl), and significantly lower levels of BDNF, a protein that supports the survival and growth of neurons. In plain terms, the markers of brain stress and damage were up, and the marker of brain resilience was down. This lent biological weight to the cognitive test results.

The vitamin findings

This is the heart of the study. Adults with MCI had significantly lower blood levels of vitamin D and several B vitamins (B1, B2, B6, and folate) than those without cognitive impairment. Deficiency was also more common in the MCI group:

  • Vitamin D deficiency: 72 percent in the MCI group versus 48 percent without MCI
  • Vitamin B2 (riboflavin) deficiency: 63 percent versus 37 percent
  • Folate (B9) deficiency: 11 percent versus 2 percent

Higher vitamin levels tracked with better cognitive scores and a lower predicted probability of MCI, and the effect was strongest for two nutrients. For vitamin D, the modeled probability of MCI fell from 0.94 at a low blood level (about 8 ng/mL) to 0.20 at a higher level (about 30 ng/mL). For vitamin B6, it dropped even more steeply, from 0.92 at low levels to 0.04 at higher levels. Vitamins B1, B2, folate, and B12 all showed the same inverse direction, though more gradually.

The researchers also tested how well vitamins distinguished MCI from normal cognition. No single vitamin was a strong standalone predictor, but combining them helped: vitamin D alone reached a modest accuracy, while a combination of vitamins D, B6, and B12 performed better, and a five-vitamin panel performed best. The signal is in the pattern, not any one nutrient.

The link between specific vitamins and brain markers

One of the more interesting findings connects nutrients directly to the brain biomarkers. Higher vitamin B2 was associated with higher BDNF (the neuroprotective marker) and lower neurofilament light chain (a marker of nerve damage). Higher vitamin B6 was associated with lower total tau. These are modest correlations, but they hint at plausible biological pathways rather than a purely statistical coincidence, which is part of what makes the results interesting.

The cardiometabolic thread

Here is the part that fits squarely with the work I do. The MCI group did not only differ in vitamins. They also had significantly higher HbA1c, a measure of average blood sugar (6.9 percent versus 6.1 percent), and higher systolic blood pressure (139 versus 131 mm Hg). In other words, the same people with poorer cognition tended to have worse metabolic health.

This is consistent with a theme I return to often: the brain is a metabolic organ, and what harms the vasculature and the metabolism tends to harm cognition too. Elevated blood sugar reflects the insulin resistance that drives so much chronic disease, and blood pressure ties into the broader cardiovascular picture. Nutrient status and cardiometabolic health are not separate stories here; they travel together. If you have read my article on the root causes of brain fog, this study reinforces two of them at once: nutrient deficiencies and blood sugar dysregulation.

The limits, stated plainly

This is where careful reading matters, because it would be easy to overstate what the study shows. Three cautions:

  • It is cross-sectional. It captured a single snapshot in time, so it cannot establish that low vitamins caused cognitive impairment. The relationship could run the other way: people with cognitive decline may eat less well, absorb nutrients less efficiently, or get less sun exposure, lowering their vitamin levels. The authors say this directly and call for longitudinal studies.
  • It was not a supplementation trial. Nothing here tells us that taking vitamins prevents or reverses cognitive decline. That question requires a different study design.
  • It was a specific population. The participants were older adults in one region of India, where certain micronutrient deficiencies are common. The pattern may not translate identically to other populations.

None of this makes the study unimportant. It makes it what it is: a well-conducted piece of evidence that strengthens a plausible link and points toward the questions worth answering next.

What this means for you

The responsible takeaways are practical and low-risk:

  • Know your levels. Ask your clinician to test vitamin D and B vitamins (including B6, B12, and folate) rather than guessing.
  • Correct real deficiencies. If you are genuinely low, repletion is sensible for many reasons beyond cognition. Correct a deficiency; do not megadose in hope of a benefit the evidence does not yet support.
  • Treat the brain as a metabolic organ. Managing blood sugar and blood pressure is cognitive care, not just heart care.
  • Eat for nutrient density. A whole-foods diet supports both micronutrient status and metabolic health, the two threads this study ties together.

The bottom line

This study adds credible weight to the idea that micronutrient status and cognition are connected, with vitamin D and B6 standing out, and it places that link alongside blood sugar and blood pressure as part of the same picture of brain aging. It does not prove that vitamins protect the brain, and it should not be read that way. But testing your nutrient status, correcting true deficiencies, and taking your metabolic health seriously are reasonable, evidence-informed steps for anyone who wants to age with a sharp mind.


Frequently asked questions

Can vitamin deficiencies cause cognitive decline?

A 2026 study in Nutrients found older adults with mild cognitive impairment had significantly lower vitamin D, B1, B2, B6, and folate, and that higher vitamin levels were associated with a lower probability of MCI. However, it was cross-sectional, so it shows association, not causation. The relationship could run in either direction.

Which vitamins were most strongly linked to cognitive impairment?

Vitamin D and B6 showed the steepest associations. For vitamin D, the predicted probability of MCI fell from 0.94 at a low level (about 8 ng/mL) to 0.20 at a higher level (about 30 ng/mL). For B6, it dropped from 0.92 to 0.04. Vitamin D deficiency was present in 72 percent of the MCI group versus 48 percent without it.

What is mild cognitive impairment (MCI)?

MCI is an intermediate stage between normal cognitive aging and dementia: noticeable changes in memory or thinking greater than expected for age but not severe enough to be dementia. It was screened here with the Montreal Cognitive Assessment (MoCA) and affected 36.4 percent of those studied.

Should I take supplements to protect my brain based on this study?

Not on this study alone. It was observational, not a supplementation trial, so it cannot show that taking vitamins prevents or reverses decline. Test for and correct genuine deficiencies with your clinician, and address related factors like blood sugar and blood pressure, rather than megadosing.


About the author: Dr. John Bartemus, DC, CFMP, is a functional medicine practitioner, educator, speaker, and Amazon international number one best-selling author focusing on cardiometabolic health, inflammation, and root-cause medicine through Functional Medicine Charlotte, PC.

This article is for educational purposes only and is not medical advice. The findings described are associations from a cross-sectional study and do not establish cause and effect. Discuss testing and any supplementation with a qualified clinician.

Source: Vepakomma V, Geereddy B, Singireddy SS, Gurrala SR, Ramanujam K, Reddy GB. “Neuronal Biomarkers and Micronutrient Status in Adults with Mild Cognitive Impairment.” Nutrients. 2026;18(15):2428. DOI 10.3390/nu18152428.